Difference between revisions of "PET Amyloid Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
(15 intermediate revisions by the same user not shown)
Line 20: Line 20:
 
==PET Amyloid Meetings/Call Summaries==
 
==PET Amyloid Meetings/Call Summaries==
  
 +
*[[Media:2022_05-13_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|May 13, 2022]]
 +
*[[Media:2022_04-15_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|April 15, 2022]]
 +
*[[Media:2022_03-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 11, 2022]]
 +
*[[Media:2022_02-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 11, 2022]]
 +
*[[Media:2022_01-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|January 14, 2022]]
  
*[[Media:2021_04-09_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS.pdf|April 9, 2021]]
 
*[[Media:2021_03-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 12, 2021]]
 
*[[Media:2021_02-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 12, 2021]]
 
  
 +
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
  
 +
==PET Amyloid Profile Development==
  
'''''[[PET Amyloid BC Call Summaries Archive]]'''''
+
For NM CC vote - Technically Confirmed:
  
==PET Amyloid Profile Development==
+
*[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-clean.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(clean version)-2022-04-14]]
 +
*[[Media:QIBA_PET Amyloid_Profile_14April2022-per-public-comment-redline.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker(marked up version)-2022-04-14]]
 +
*[[Media:QIBA_PET Amyloid_Profile_Updates_15April2022.pdf | Profile Updates Summary-2022-04-15]]
 +
----------------------------------------------------------
  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]]  

Revision as of 15:42, 6 May 2022

Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
RSNA Staff Support: Julie Lisiecki


Project Snapshot

There is a draft Profile, and current outline of the Claim is:

  • SUVr will be the measurand
  • The claim will have two components
1) Cross-sectional: single subject scan
2) Longitudinal: following subject over time

Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.

Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)

PET Amyloid Meetings/Call Summaries


PET Amyloid BC Call Summaries Archive

PET Amyloid Profile Development

For NM CC vote - Technically Confirmed:


Profile Supporting Material

Working Documents

Presentations and Reports

QIBA Funded Projects

Round 4

Round 5